With Patrick Kierans, Richard Wagner, Kristin Wall
Norton Rose Group’s head of pharmaceuticals and life sciences, Patrick Kierans (based in Toronto), together with partners Richard A. Wagner (Ottawa) and Mélanie Thill-Tayara (Paris), assess the recent response by Canadian generic manufacturers to proposed reform of intellectual property law in Canada.